Tirzepatide is approximately two years into widespread availability (approved 2022-2023), making it newer than semaglutide but mature enough that millions of patient-months of real-world safety and efficacy data now exist
It should be noted that the chills are not a common side effect for Ozempic and Wegovy, though side effects may vary from person to person
What impact do you think fully oral GLP-1 therapies could have on long-term patient adherence and accessibility
Unfortunately, the representative I spoke to could not give details on pricing and stated it would depend on the pharmacy, my insurance and other factors
This means contents, including archaea, are not properly moving through and out of the small intestine, potentially causing an increase in the number of bacteria or archaea (i.e
Greger also compares these risks with those of obesity